
Striving for Consensus on the Management of ALK-Positive Lung Cancer
Lung Cancer Update
00:00
The Neurocognitive Effects of Lore Latinib
ABI de Gogo Jackiner group recently published a paper trying to look at factors associated with the neurocognitive and mood effects of lore latinib. I think electinib or bergatin both would be perfectly acceptable agents. The toxicity is manageable with dose dose reduction, but docs need to use drugs that they're familiar with managing.
Transcript
Play full episode